Stockreport

RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell Transfer at SITC 2018

RXI PHARMACEUTICALS CORP  (RXII) 
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am Check Earnings Report
US:NASDAQ Investor Relations: investors.rxipharma.com
PDF MARLBOROUGH, Mass., Nov. 7, 2018 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing the next generation of immuno-oncolog [Read more]